Facebook Pixel Code

Rekvina Laboratories Share Price

NSE
BSE

REKVINA LABORATORIES

Smallcap | BSE

Here's the live share price of Rekvina Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹61.98 Closed
5.00₹ 2.95
As on Oct 14, 2026, 04:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Source: Dion Global

Rekvina Laboratories Price Performance

Today's LowToday's High
₹57.00₹61.98
₹61.98
52 Weeks' Low52 Weeks' High
₹6.75₹61.98
₹61.98
Open Price
₹61.98
Prev. Close
₹59.03
Volume
11,295

Source: Dion Global

Rekvina Laboratories Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Rekvina Laboratories
18.066.2280.7049.46775.42106.1068.97
Sun Pharmaceutical Industries
-1.93-4.69-9.863.085.7315.5115.77
Divi's Laboratories
-5.74-1.7425.6746.1937.6735.1510.94
Torrent Pharmaceuticals
-2.46-5.28-7.5910.5430.5433.9524.03
Zydus Lifesciences
-2.602.27-0.8720.0914.7923.9515.61
Laurus Labs
-0.925.8830.5382.28132.2772.2325.62
Cipla
-1.25-3.54-8.747.03-15.474.087.57
Dr. Reddy's Laboratories
0.975.60-2.54-0.34-1.873.414.12
Aurobindo Pharma
-1.49-0.306.9020.6847.7522.2217.96
Mankind Pharma
-6.601.81-7.929.78-4.358.6810.35
Lupin
-2.61-4.89-20.84-16.430.8917.7215.62
Glenmark Pharmaceuticals
-1.85-5.49-2.65-0.6918.5241.1933.73
Alkem Laboratories
-2.721.14-6.87-6.50-5.1113.056.02
Biocon
-2.57-7.81-19.680.23-0.1411.390.20
Abbott India
0.230.01-4.990.68-13.145.193.95
Gland Pharma
-3.465.6422.3573.2958.5924.55-4.24
Ipca Laboratories
-1.27-1.024.0530.1146.7825.729.60
Anthem Biosciences
-4.40-10.0113.0616.309.795.113.03
GlaxoSmithKline Pharmaceuticals
-3.51-9.713.145.60-8.0418.1811.39
Ajanta Pharma
-6.35-4.66-2.0915.7539.7323.9717.77

Source: Dion Global

Over the last one year, Rekvina Laboratories has gained 775.42% compared to peers like Sun Pharmaceutical Industries (5.73%), Divi's Laboratories (37.67%), Torrent Pharmaceuticals (30.54%). From a 5 year perspective, Rekvina Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (15.77%) and Divi's Laboratories (10.94%).

Rekvina Laboratories Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Source: Dion Global

Rekvina Laboratories Stock Technicals

Moving Average

DaySMAEMA
552.8653.37
1050.9852.44
2053.1851.75
5045.6647.53
10040.9142.1
20031.7433.95

Source: Dion Global

Rekvina Laboratories Share Holding Pattern

In the latest quarter, Rekvina Laboratories saw a rise in promoter holding to 77.00%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 23.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Rekvina Laboratories Corporate Actions

Date Time
Announcement
Oct 08, 2026, 01:03 AM IST ISTRekvina Laboratories - Announcement under Regulation 30 (LODR)-Change in Management
Sep 30, 2026, 12:52 AM IST ISTRekvina Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 29, 2026, 11:22 PM IST ISTRekvina Laboratories - Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 24, 2026, 01:21 AM IST ISTRekvina Laboratories - Announcement Under Reg. 30 Of SEBI (LODR) Regulation 2015 - Noting Of Resignation
Sep 24, 2026, 01:19 AM IST ISTRekvina Laboratories - Announcement under Regulation 30 (LODR)-Change in Registered Office Address

Source: Dion Global

About Rekvina Laboratories

Rekvina Laboratories Ltd. is a Public Limited Listed company incorporated on 01/11/1988 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ1988PLC011458 and registration number is 011458. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 1.27 Cr. and Equity Capital is Rs. 3.01 Cr. for the Year ended 31/03/2026.

Source: Dion Global

Management

  • Mr. Amit Mukesh Shah
    Managing Director
  • Mrs. Ilaben Pathak
    Non Exe.Non Ind.Director
  • Mr. Surbhit Shah
    Executive Director & CFO
  • Mr. Jay Chintan Patel
    Independent Director
  • Mr. Prateek Satishkumar Jain
    Independent Director

FAQs on Rekvina Laboratories Share Price

What is the share price of Rekvina Laboratories?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Rekvina Laboratories is ₹61.98 as on Oct 14, 2026.

What kind of stock is Rekvina Laboratories?

The Rekvina Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Rekvina Laboratories?

The market cap of Rekvina Laboratories is ₹37.36 Cr as on Oct 14, 2026.

What are today's High and Low prices of Rekvina Laboratories?

Today’s highest and lowest price of Rekvina Laboratories are ₹61.98 and ₹57.00.

What are the 52 Week High and 52 Week Low of Rekvina Laboratories?

The 52-week high/low is the highest and lowest price at which Rekvina Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Rekvina Laboratories is ₹61.98 and 52-week low of Rekvina Laboratories is ₹6.75 as on Oct 14, 2026.

How has the Rekvina Laboratories performed historically in terms of returns?

The Rekvina Laboratories has shown returns of 5.0% over the past day, 6.22% for the past month, 80.7% over 3 months, 775.42% over 1 year, 106.1% across 3 years, and 68.97% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Rekvina Laboratories?

P/E ratio of and PB ratio of Rekvina Laboratories are -109.99 and -27.70 on Oct 14, 2026. While the company gives a dividend yield of 0.00 per annum.

Source: Dion Global

Rekvina Laboratories News